Toggle light / dark theme

Scale of living things

Neal Agarwal published another gift to the internet with Size of Life. It shows the scale of living things, starting with DNA, to hemoglobin, and keeps going up.

The scientific illustrations are hand-drawn (without AI) by Julius Csotonyi. Sound & FX by Aleix Ramon and cello music by Iratxe Ibaibarriaga calm the mind and encourage a slow observation of things, but also grow in complexity and weight with the scale. It kind of feels like a meditation exercise.

See also: shrinking to an atom, the speed of light, and of course the classic Powers of Ten.

Polarized light boosts accuracy of wearable health sensors for all skin tones

Photoplethysmography (PPG) is an optical sensing technique that measures blood volume changes and underpins devices ranging from hospital-grade pulse oximeters to consumer wearables that track heart rate, sleep, and oxygenation.

Despite its widespread use, PPG accuracy can vary significantly across individuals, particularly by skin tone. Darker skin contains more melanin, which absorbs and scatters light, often leading to less reliable readings. This disparity has been linked to inaccuracies in blood-oxygen measurements among people with more melanin.

Abstract: For those interested in fertility regulation, endometriosis, adenomyosis, and endometrial cancer…

Francesco J. DeMayo & team discover uterine ZMIZ1 co-regulates estrogen receptor to establish and maintain pregnancy and general uterine health via cell growth responses and preventing uterine fibrosis:

The figure shows epithelial cell DNA synthesis (reflected by EdU incorporation) was inhibited by Zmiz1 deletion.


1Pregnancy & Female Reproduction Group, Reproductive and Development al Biology Lab, NIEHS, Research Triangle Park, North Carolina, USA.

2Inotiv-RTP, Durham, North Carolina, USA.

3Division of Hematology-Oncology, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.

Medications change our gut microbiome in predictable ways

The bacteria in our poop are a reasonable representation of what’s living in our digestive system. To understand how different drugs can impact the gut microbiome, the team cultured microbial communities from nine donor fecal samples and systematically tested them with 707 different clinically relevant drugs.

The researchers examined changes in the growth of different bacterial species, the community composition, and the metabolome – the mix of small molecules called metabolites that microbes produce and consume. They found that 141 drugs altered the microbiome of the samples and even short-term treatments created enduring changes, entirely wiping out some microbial species. The primary force behind how the community responds to drug inhibition was competition over nutrients.

“The winners and losers among our gut bacteria can often be predicted by understanding how sensitive they are to the medications and how they compete for food,” said the first author on the paper. “In other words, drugs don’t just kill bacteria; they also reshuffle the ‘buffet’ in our gut, and that reshuffling shapes which bacteria win.”

Despite the complexity of the bacterial communities, the researchers were able to create data-driven computer models that accurately predicted how they would respond to a particular drug. They factored in the sensitivity of different bacterial species to that drug and the competitive landscape – essentially, who was competing with whom for which nutrients.

Their work provides a framework for predicting how a person’s microbial community might change with a given drug, and could help scientists find ways to prevent these changes or more easily restore a healthy gut microbiome in the future.


Our gut microbiome is made up of trillions of bacteria and other microbes living in our intestines. These help our bodies break down food, assist our immune system, send chemical signals to our brain, and potentially serve many other functions that researchers are still working to understand. When the microbiome is out of balance – with not enough helpful bacteria or the wrong combination of microbes – it can affect our whole body.

Registration of Brazil’s dengue vaccine officially announced

The Ministry of Health intends to begin administering doses in 2026, free of charge, through the SUS, the country’s national heal care network.

In a statement, Anvisa reported that the publication makes official the conclusion of the regulatory process and enables the production and sale of the vaccine, which will be offered exclusively through the public health system.

“The registration is a milestone in the fight against dengue in Brazil. The vaccine has undergone all the technical and regulatory stages required by health legislation, ensuring its safety, quality, and efficacy,” the text reads.

Researchers detect early brain changes linked to future psychosis development

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), and NHG Health’s Institute of Mental Health (IMH) have mapped how brain networks differ in individuals at Clinical High Risk (CHR) for psychosis, providing a new perspective on the mechanisms underlying the disease onset.

Published in Molecular Psychiatry, the study utilized advanced neuroimaging methods to identify early, network-level changes in more than 3,000 individuals at varying levels of risk.

The study—led by Dr. Siwei Liu, Senior Research Scientist, and Associate Professor Juan Helen Zhou, Director, both at the Center for Translational Magnetic Resonance Research (TMR), NUS Medicine, and in collaboration with Associate Professor Jimmy Lee, Senior Consultant Psychiatrist and Clinician-Scientist at IMH—sought to determine how brain networks can reveal signs in young individuals with heightened clinical risk of developing psychosis.

Parenting styles play a key role in shaping teen mental health

Mental health is a global crisis, with more than 1 billion people affected by mental health conditions, according to the World Health Organization (WHO). Young people are particularly affected, with suicide as the third leading cause of death among those aged 15 to 29. A new study of the mental health of Nepali adolescents published in the journal PLOS One found that more than 40% of teens suffer from anxiety and that parenting style is a major factor influencing mental well-being.

A research team led by Rabina Khadka, a public health lecturer at the Manmohan Memorial Institute of Health Sciences in Kathmandu, surveyed 583 school-going adolescents in Bheemdatt Municipality, Nepal. The aim was to fill in gaps in the existing data, specifically the lack of research on how different parenting styles (authoritative, authoritarian and permissive) relate to a range of mental health outcomes.

Participants were asked to fill out a four-part survey with questions covering their mental health status (levels of depression, anxiety, stress and self-esteem), perceived parenting style and personal information such as age, gender and family situation. The researchers then measured these factors using recognized psychological scales and analyzed the data to find statistical links between the type of parenting teens received and their mental health.

For those living with dementia, new study suggests shingles vaccine could slow the disease

An unusual public health policy in Wales may have produced the strongest evidence yet that a vaccine can reduce the risk of dementia. In a new study led by Stanford Medicine, researchers analyzing the health records of Welsh older adults discovered that those who received the shingles vaccine were 20% less likely to develop dementia over the next seven years than those who did not receive the vaccine.

The remarkable findings, published April 2 in Nature, support an emerging theory that viruses that affect the nervous system can increase the risk of dementia. If further confirmed, the new findings suggest that a preventive intervention for dementia is already close at hand.

In a follow-up study published Dec. 2 in Cell, the researchers found that the vaccine may also benefit those already diagnosed with dementia by slowing the progress of the disease.

/* */